COVID-19及其对过敏诊所常见疾病的影响
Emek Kocatürk1, Elissa M Abrams2, Marcus Maurer3
1Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
The journal of allergy and clinical immunology. In practice
|September 3, 2023
概括
喘和鼻炎等过敏性疾病可以影响COVID-19的严重程度和结果. 保持对这些疾病的控制对于在疫情期间更好的管理至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 皮肤病学 皮肤病学
背景情况:
- 冠状病毒疾病2019 (COVID-19),由SARS-CoV-2引起,影响过敏状况.
- 过敏性疾病可以影响COVID-19的过程和严重程度.
- 在大流行期间,过敏性疾病的管理发生了转变.
研究的目的:
- 审查COVID-19和过敏性疾病之间的双向关系.
- 了解COVID-19如何影响喘,过敏性鼻炎,亚托皮炎和疹.
- 为了突出疫情期间过敏疾病管理的变化.
主要方法:
- 文献综述和当前证据的综合.
- 对COVID-19对过敏性疾病恶化影响的分析.
- 检查疫情期间对过敏状况的治疗修改.
主要成果:
- 控制不良的喘与严重的COVID-19有关;与较低死亡率相关的过敏性喘.
- 鼻内皮质类固醇与过敏性鼻炎的COVID-19住院时间较低有关.
- 生物治疗可以减少慢性疹和皮炎的恶化.
结论:
- 在流行病期间,保持对过敏疾病的控制至关重要.
- COVID-19 管理需要意识到其对过敏状况的影响.
- 在大流行期间,远程医疗和家庭护理对于管理过敏疾病至关重要.
相关概念视频
Allergic Reactions
27.8K
Overview
27.8K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875
Drugs Used in Lower Respiratory Disorders: Overview
487
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
487
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


